1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [0e1f344d-0f9b-47da-b864-6cacc5bda479] => Array
        (
            [runtime-id] => 0e1f344d-0f9b-47da-b864-6cacc5bda479
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [efd9fd0b-68e2-46c9-8205-4b5bd372bb0c] => Array
                        (
                            [runtime-id] => efd9fd0b-68e2-46c9-8205-4b5bd372bb0c
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;265e054cb15f13d528f47cc480a1bac228271b08
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [0e1f344d-0f9b-47da-b864-6cacc5bda479] => Array
        (
            [runtime-id] => 0e1f344d-0f9b-47da-b864-6cacc5bda479
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [efd9fd0b-68e2-46c9-8205-4b5bd372bb0c] => Array
                        (
                            [runtime-id] => efd9fd0b-68e2-46c9-8205-4b5bd372bb0c
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;265e054cb15f13d528f47cc480a1bac228271b08
                )

        )

)


Table 1: 
Diagnosis of all patientsa
DiagnosisNo.Percentage
Adeno ca parotid gland11%
Angiosarcoma11%
B-cell lymphoma11%
Lung carcinoma22%
Melanoma66%
Merkel cell carcinoma22%
Rhabdomyosarcoma11%
SCC hypopharyngeal77%
SCC laryngeal1617%
SCC nasal cavity sinus44%
SCC nasopharyngeal11%
SCC oral cavity1920%
SCC oropharyngeal2526%
SCC skin11%
SCC unknown primary66%
Second branchial cleft11%
Tuberculosis11%
Unknown primary11%
Total96100%
  • Note:—Aneno ca indicates adenocarcinoma; SCC, squamous cell carcinoma.
  • ↵a In total, 82% of all patients had SCC.